Greg Rosenfeld

3.5k total citations
75 papers, 1.2k citations indexed

About

Greg Rosenfeld is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Greg Rosenfeld has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 27 papers in Epidemiology and 26 papers in Surgery. Recurrent topics in Greg Rosenfeld's work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (22 papers) and Venomous Animal Envenomation and Studies (10 papers). Greg Rosenfeld is often cited by papers focused on Inflammatory Bowel Disease (35 papers), Microscopic Colitis (22 papers) and Venomous Animal Envenomation and Studies (10 papers). Greg Rosenfeld collaborates with scholars based in Canada, United States and United Kingdom. Greg Rosenfeld's co-authors include Brian Bressler, Hong Qian, Uri Kopylov, Ernest G. Seidman, Yvette Leung, E.M.A. Kelen, Robert Enns, Janakie Singham, H Wiesinger and Édouard Louis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cochrane Database of Systematic Reviews.

In The Last Decade

Greg Rosenfeld

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Rosenfeld Canada 18 706 523 388 135 133 75 1.2k
Tibor Hlavatý Slovakia 17 702 1.0× 652 1.2× 331 0.9× 144 1.1× 120 0.9× 58 1.3k
Pierre Ellul Malta 23 463 0.7× 359 0.7× 348 0.9× 155 1.1× 127 1.0× 89 1.3k
Beverly M. Calkins United States 15 707 1.0× 559 1.1× 394 1.0× 159 1.2× 80 0.6× 20 1.3k
W Tillinger Austria 16 825 1.2× 674 1.3× 297 0.8× 154 1.1× 107 0.8× 27 1.6k
C. Canavan United Kingdom 9 447 0.6× 397 0.8× 327 0.8× 109 0.8× 173 1.3× 15 1.1k
William Koltun United States 24 410 0.6× 243 0.5× 166 0.4× 90 0.7× 143 1.1× 41 1.6k
Tran M Nguyen Canada 23 952 1.3× 722 1.4× 420 1.1× 119 0.9× 169 1.3× 64 1.6k
Roy E. Pounder United Kingdom 23 505 0.7× 548 1.0× 647 1.7× 132 1.0× 98 0.7× 41 1.7k
Edward J. Feldman United States 16 325 0.5× 196 0.4× 283 0.7× 126 0.9× 51 0.4× 32 1.1k
Pontus Karling Sweden 20 385 0.5× 339 0.6× 347 0.9× 347 2.6× 163 1.2× 65 1.3k

Countries citing papers authored by Greg Rosenfeld

Since Specialization
Citations

This map shows the geographic impact of Greg Rosenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Rosenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Rosenfeld more than expected).

Fields of papers citing papers by Greg Rosenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Rosenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Rosenfeld. The network helps show where Greg Rosenfeld may publish in the future.

Co-authorship network of co-authors of Greg Rosenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Rosenfeld. A scholar is included among the top collaborators of Greg Rosenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Rosenfeld. Greg Rosenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Solitano, Virginia, Ropo Ebenezer Ogunsakin, Yuhong Yuan, et al.. (2025). Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study. The American Journal of Gastroenterology. 121(2). 410–423. 1 indexed citations
3.
Rosenfeld, Greg, et al.. (2024). A Rare Case of Gastric Extranodal NK/T-Cell Lymphoma With Orbital Involvement. ACG Case Reports Journal. 11(3). e01280–e01280.
4.
Bressler, Brian, et al.. (2024). Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, Canada. Journal of the Canadian Association of Gastroenterology. 7(4). 299–305. 1 indexed citations
5.
Rosenfeld, Daniel, et al.. (2024). Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease. World Journal of Gastroenterology. 30(46). 4904–4913. 1 indexed citations
6.
McCurdy, Jeffrey D., Joseph Meserve, Tim Ramsay, et al.. (2023). Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study. Clinical Gastroenterology and Hepatology. 22(5). 1058–1066.e2. 6 indexed citations
7.
Zhang, Wei, et al.. (2019). Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease. BMJ Open. 9(4). e027043–e027043. 13 indexed citations
8.
Rosenfeld, Greg, et al.. (2019). Patterns and motivations of Cannabis use amongst patients with inflammatory bowel disease. 1(3). 100–107. 8 indexed citations
9.
Bressler, Brian, et al.. (2018). A120 PREVALENCE OF ANXIETY AND DEPRESSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Journal of the Canadian Association of Gastroenterology. 1(suppl_1). 211–211. 1 indexed citations
10.
Huang, Vivian, Raymond Bourdages, Richard N. Fedorak, et al.. (2018). IBDoc Canadian User Performance Evaluation. Inflammatory Bowel Diseases. 25(6). 1107–1114. 9 indexed citations
11.
Ghosh, Subrata, Édouard Louis, Laurent Beaugerie, et al.. (2017). Development of the IBD Disk. Inflammatory Bowel Diseases. 23(3). 333–340. 73 indexed citations
12.
Rosenfeld, Greg, et al.. (2016). FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World Journal of Gastroenterology. 22(36). 8211–8211. 7 indexed citations
13.
Bressler, Brian, et al.. (2016). Medical Imaging in Small Bowel Crohnʼs Disease—Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound. Inflammatory Bowel Diseases. 22(5). 1246–1261. 56 indexed citations
14.
Ou, George, et al.. (2015). Colonoscopy after CT-diagnosed acute diverticulitis: Is it really necessary?. Canadian Journal of Surgery. 58(4). 226–231. 21 indexed citations
15.
Rosenfeld, Greg. (2014). Does training and experience influence the accuracy of computed tomography colonography interpretation?. World Journal of Gastroenterology. 20(6). 1574–1574. 2 indexed citations
16.
Rush, Barret, et al.. (2014). Tacrolimus Therapy for Ulcerative Colitis-Associated Post-Colectomy Enteritis. ACG Case Reports Journal. 2(1). 33–35. 13 indexed citations
17.
Rosenfeld, Greg, Hong Qian, & Brian Bressler. (2013). The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: A systematic review and meta-analysis. Journal of Crohn s and Colitis. 7(11). 868–877. 78 indexed citations
18.
Rosenfeld, Greg, et al.. (2011). Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report. Journal of Medical Case Reports. 5(1). 138–138. 18 indexed citations
19.
Nof, Eyal, Héctor Barajas-Martínez, M. Eldar, et al.. (2011). LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current. EP Europace. 13(10). 1478–1483. 20 indexed citations
20.
Kelen, E.M.A., et al.. (1960). Hemolytic Activity of Animal Venoms. II Variation in relation to Erythrocyte Species.. 30. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026